Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
13.02
-1.93 (-12.91%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $2.46 billion as of April 28, 2026. Its market cap has increased by 554.60% in one year.
Market Cap
2.46B
Enterprise Value
2.02B
1-Year Change
554.60%
Ranking
Category
Stock Price
$13.02
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $2.46B, a decrease of -18.83%. That is a compound annual growth rate of -3.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 2.73B |
| Vera Therapeutics | 2.72B |
| Celldex Therapeutics | 2.66B |
| Immunome | 2.63B |
| Tarsus Pharmaceuticals | 2.63B |
| Disc Medicine | 2.63B |
| Enliven Therapeutics | 2.62B |
| IDEAYA Biosciences | 2.58B |